Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
about
Meeting report: mode(s) of action of asbestos and related mineral fibersRole of mutagenicity in asbestos fiber-induced carcinogenicity and other diseasesAssessment of the Mutagenicity of Sediments from Yangtze River Estuary Using Salmonella Typhimurium/Microsome AssayEffects of Perivitelline Fluid Obtained from Horseshoe Crab on The Proliferation and Genotoxicity of Dental Pulp Stem CellsTransgenic rat models for mutagenesis and carcinogenesisRecommendations for the evaluation of complex genetic toxicity data sets when assessing carcinogenic risks to humans.The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides.Integration of in vivo genotoxicity and short-term carcinogenicity assays using F344 gpt delta transgenic rats: in vivo mutagenicity of 2,4-diaminotoluene and 2,6-diaminotoluene structural isomers.Can carcinogenic potency be predicted from in vivo genotoxicity data?: a meta-analysis of historical data.The Salmonella mutagenicity assay: the stethoscope of genetic toxicology for the 21st century.Review of genotoxicity studies of glyphosate and glyphosate-based formulations.Present state and future perspectives of using pluripotent stem cells in toxicology researchToxicological screeningGenetic toxicology in the 21st century: reflections and future directions.Evaluating the genotoxicity of urban PM2.5 using PCR-based methods in human lung cells and the Salmonella TA98 reverse test.Correlation of In Vivo Versus In Vitro Benchmark Doses (BMDs) Derived From Micronucleus Test Data: A Proof of Concept StudyGenotoxicity of styrene-acrylonitrile trimer in brain, liver, and blood cells of weanling F344 rats.Dose-response assessment of four genotoxic chemicals in a combined mouse and rat micronucleus (MN) and Comet assay protocol.Follow-up actions from positive results of in vitro genetic toxicity testing.Solution by dilution?--A review on the pollution status of the Yangtze River.Using immunotoxicity information to improve cancer risk assessment for polycyclic aromatic hydrocarbon mixtures.Antimutagenic compounds and their possible mechanisms of action.Applying the erythrocyte Pig-a assay concept to rat epididymal sperm for germ cell mutagenicity evaluation.In vitro mutagenic, antimutagenic, and antioxidant activities evaluation and biotransformation of some bioactive 4-substituted 1-(2-methoxyphenyl)piperazine derivatives.Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.A review of the carcinogenic potential of glyphosate by four independent expert panels and comparison to the IARC assessment.Genotoxicity Expert Panel review: weight of evidence evaluation of the genotoxicity of glyphosate, glyphosate-based formulations, and aminomethylphosphonic acid.Comparison of in vitro test systems using bacterial and mammalian cells for genotoxicity assessment within the "health-related indication value (HRIV) concept.Architecture in 3D cell culture: An essential feature for in vitro toxicology.Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation.Dose-response mutation and spectrum analyses reveal similar responses at two microsatellite loci in benzo(a)pyrene-exposed mouse spermatogonia.Evaluation of the mutagenicity of simple substituted quinoxalines in Salmonella typhimurium.Cerium dioxide nanoparticles affect in vitro fertilization in mice.Chrysotile and rock wool fibers induce chromosome aberrations and DNA damage in V79 lung fibroblast cells.Comparison of Comet assay dose-response for ethyl methanesulfonate using freshly prepared versus cryopreserved tissues.Performance of in vitro γH2AX assay in HepG2 cells to predict in vivo genotoxicity.DNA-based mutation assay GPMA (genome profiling-based mutation assay): reproducibility, parts-per-billion scale sensitivity, and introduction of a mammalian-cell-based approach.Parental exposure to methyl methane sulfonate of three-spined stickleback: contribution of DNA damage in male and female germ cells to further development impairment in progeny.Declaring the existence of human germ-cell mutagens.Evaluation of the highest concentrations used in the in vitro chromosome aberrations assay.
P2860
Q23918083-364CD3DF-5F27-49E4-B5A9-1C32E5EB0BD4Q28389566-C72259D7-5EC1-427B-9314-BB4633396127Q28551176-8A221EC1-D90F-4D70-BBD9-657B718908CDQ28647002-3D16060C-EA9A-4BBE-AA00-87A8CE8C6C60Q28817612-FDBE574F-BACF-478D-9908-E519E29B672CQ31171476-2BF06079-300C-4A4D-A668-B3A2B1B12422Q33530406-4F4AD159-1500-4871-B271-DA2977971993Q33645056-244A3888-2C87-492D-A897-8D144E17BDBFQ33889666-CF3FA02F-C8C7-44E3-AC37-4812CED2E324Q34282785-7FCF08E4-B8AD-4549-ABA1-3D2D6E60D6A1Q34332334-19552BD5-36E8-42BF-924D-C430D93900C5Q34520935-0406E13F-7148-47FA-87EF-BD042258716DQ35079846-A8B1E7A7-11E9-43DB-A6DB-A15E56F2AD34Q35177174-D1DA5A28-4503-4DDD-BC74-59BAA759EBA9Q35228216-1A0B4532-19C4-45D8-ADD1-B876458DA5ECQ35800710-3D64C4A9-A1DD-4A70-9E7F-48089D782B44Q36462340-6C6C0309-14A2-40F1-9F5B-EECC66A3558DQ36462353-CB3CAA95-6CB2-4273-91BE-6B922C88ECD5Q37801886-F60649CD-9490-4D9F-8BEF-E66675CF91EFQ38100938-C381FD84-D66D-4D8C-8839-D7C1763A96FFQ38127167-16A08402-CD9A-4064-B5AE-73FD46F35A4FQ38194959-B6C2615C-21A1-4585-BCB9-59F958F96E63Q38676314-E53249D0-6EC3-46A5-8294-E1F95271201FQ38838563-B5182C4A-0885-4179-803A-D4A035D8B670Q38960123-6A046145-68E1-4174-9DA9-EA2062846AA5Q38966150-8A794454-360D-469B-9EE4-50C3229BF028Q38966164-627E11FF-A89E-47E7-9B8D-03001BCD3EFDQ39121042-C93D4568-C77E-4888-9718-00B04CE975ADQ39213995-D179D3F6-4C5A-430B-AC0F-A8BD664D4F82Q39311280-0662E0A7-1874-4422-AE4C-C051CFD6AE31Q40175200-71CDA8FD-82A1-4BEF-8A43-2E00C39B1A70Q40544428-FAA09EC8-1673-4519-AE30-38DDDF2B6E2EQ40911272-768169C5-94A9-4D76-B78D-B7C89600912DQ43363915-2892F380-2391-499B-8841-1E241018A9E7Q43806868-62EF137D-CE25-4D0C-BF78-525889ACC47CQ45816957-CA1DAD75-4248-408D-926C-4BFB1A700E87Q46251891-21CDB9E7-1E9E-48B8-BC71-AEF6F9DA1CD8Q46319824-45BBB72F-F3FB-4818-BF04-8D31194EEB48Q46320988-5FF0FB78-4CB1-43EB-B706-58D9A2177F92Q46492014-754D9B9D-478D-454C-88E1-156351F5226C
P2860
Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@en
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@nl
type
label
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@en
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@nl
prefLabel
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@en
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@nl
P2093
P2860
P356
P1433
P1476
Mutagenicity testing for chemi ...... he WHO/IPCS Harmonized Scheme.
@en
P2093
Andrea Hartwig
Carolyn Vickers
David A Eastmond
Diana Anderson
George R Douglas
Ivan Dobrev
Michael C Cimino
Takehiko Nohmi
Wagida A Anwar
P2860
P304
P356
10.1093/MUTAGE/GEP014
P577
2009-06-17T00:00:00Z